NCT07290881 Comparing the Postoperative Analgesic Efficacy of Anterior Iliac Block and Ilioinguinal-iliohypogastric Block in Inguinal Hernia Surgery
| NCT ID | NCT07290881 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Harran University |
| Condition | Acute Pain |
| Study Type | INTERVENTIONAL |
| Enrollment | 60 participants |
| Start Date | 2026-04-20 |
| Primary Completion | 2026-09-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 60 participants in total. It began in 2026-04-20 with a primary completion date of 2026-09-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The primary aim of this study is to compare two postoperative analgesia techniques used in patients undergoing inguinal hernia surgery-(1) the anterior iliac block and (2) the ilioinguinal/iliohypogastric block-in terms of postoperative analgesia duration and patient satisfaction. Effective postoperative analgesia in inguinal hernia surgery is crucial for improving patient comfort and reducing opioid consumption. Although ilioinguinal and iliohypogastric nerve blocks are commonly used for this purpose, their relatively limited dermatomal coverage may result in inadequate analgesia in some cases. The recently described Anterior Iliac Block has been proposed as an alternative to conventional techniques, offering potentially wider neural spread and more effective postoperative pain control. However, the efficacy and safety of this novel block have not yet been sufficiently evaluated in the literature.
Eligibility Criteria
Inclusion Criteria: * It includes patients aged 18-65 years * Classified as ASA I-II * Who are undergoing elective inguinal hernia surgery Exclusion Criteria: * Patients who did not wish to participate voluntarily * Those with contraindications to the anterior iliac block or the Ilioinguinal/Iliohypogastric block, * Pregnant or breastfeeding women * Patients classified as ASA III-IV-V
Frequently Asked Questions
Who can join the NCT07290881 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, up to 65 Years, studying Acute Pain. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT07290881 currently recruiting?
Yes, NCT07290881 is actively recruiting participants. Visit ClinicalTrials.gov or contact Harran University to inquire about joining.
Where is the NCT07290881 trial being conducted?
This trial is being conducted at Şanliurfa, Turkey (Türkiye).
Who is sponsoring the NCT07290881 clinical trial?
NCT07290881 is sponsored by Harran University. The trial plans to enroll 60 participants.